Nano-formulation of darkness hormone could be therapeutic solution for Parkinson's disease
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
The company has raised US$4.5 million in funding for its AI operating system
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Nanoform will receive access to compound libraries and large data sets to undertake STARMAP screening
NGS enables researchers to quickly sequence entire genomes and transcriptomes of organisms.
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
New mass spectrometry instrument and consumables launch during IMSC 2022
Merck’s first microbiology application and training lab in India
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
Subscribe To Our Newsletter & Stay Updated